https://www.selleckchem.com/pr....oducts/gsk1838705a.h
Background The pathologic process of ARVC (arrhythmogenic right ventricular cardiomyopathy) typically originates in the epicardium or subepicardial layers with progression toward endocardium. However, in the most recent ARVC international task force consensus statement, epicardial ventricular tachycardia (VT) ablation is recommended as a Class I indication only in patients with at least one failed endocardial VT ablation attempt. Objective The aim of this meta-analysis is to assess the outcomes of ARVC patients undergoing combined e
Like
Comment
Share
